Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (4489)	9/29/2005 10:05:13 AM
From: sjemmeri	Read Replies (1) of 4974

9/29/2005 GHDX Diagnostic test maker Genomic Health prices shares at $12 Genomic Health, a life science company developing genomic-based clinical diagnostic tests for cancer, priced 5.0 million shares at $12, the low end of its proposed $12-$14 range. The company currently markets a test targeting early stage breast cancer patients and has performed 3,000 such tests so far this year. J.P. Morgan and Lehman Brothers were the underwriters on the deal. Expect the stock to begin trading today on the NASDAQ under the symbol "GHDX." 9/29/2005 AVRX Biotech Avalon Pharmaceuticals prices at $10.50 Avalon Pharmaceuticals, a genomics company developing small molecule therapies for the treatment of cancer, priced its IPO of 2.75 million shares at $10.50, within its proposed $10 to $12, on Thursday morning. The IPO was performed in the auction-based "Open IPO" process led by WR Hambrecht. The stock is expected to begin trading on the NASDAQ under the ticker AVRX on Thursday

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next